Cellular mechanisms and role of endothelin-1-induced calcium oscillations in pulmonary arterial myocytes

Am J Physiol. 1998 Aug;275(2):L269-82. doi: 10.1152/ajplung.1998.275.2.L269.

Abstract

The effect of endothelin (ET)-1 on both cytosolic Ca2+ concentration ([Ca2+]i) and membrane current in freshly isolated myocytes, as well as on the contraction of arterial rings, was investigated in rat main pulmonary artery (RMPA) and intrapulmonary arteries (RIPA). ET-1 (5-100 nM, 30 s) induced a first [Ca2+]i peak followed by 3-5 oscillations of decreasing amplitude. In RMPA, the ET-1-induced [Ca2+]i response was fully abolished by BQ-123 (0.1 microM). In RIPA, the response was inhibited by BQ-123 in only 21% of the cells, whereas it was abolished by BQ-788 (1 microM) in 70% of the cells. In both types of arteries, the response was not modified in the presence of 100 microM La3+ or in the absence of external Ca2+ but disappeared after pretreatment of the cells with thapsigargin (1 microM) or neomycin (0.1 microM). In RPMA myocytes clamped at -60 mV, ET-1 induced an oscillatory inward current, the reversal potential of which was close to the equilibrium potential for Cl-. This current was unaltered by the removal of external Ca2+ but was abolished by niflumic acid (50 microM). In arterial rings, the ET-1 (100 nM)-induced contraction was decreased by 35% in the presence of either niflumic acid (50 microM) or nifedipine (1 microM). These results demonstrate that ET-1 via the ETA receptor only in RMPA and both ETA and ETB receptors in RIPA induce [Ca2+]i oscillations due to iterative Ca2+ release from an inositol trisphosphate-sensitive Ca2+ store. Ca2+ release secondarily activates an oscillatory membrane Cl- current that can depolarize the cell membrane, leading to an influx of Ca2+, this latter contributing to the ET-1-induced vasoconstrictor effect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Caffeine / pharmacology
  • Calcium / metabolism*
  • Endothelin Receptor Antagonists
  • Endothelin-1 / pharmacology*
  • Endothelin-1 / physiology
  • Inositol 1,4,5-Trisphosphate / metabolism
  • Isometric Contraction / drug effects
  • Isometric Contraction / physiology
  • Kinetics
  • Male
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiology*
  • Neomycin / pharmacology
  • Niflumic Acid / pharmacology
  • Oligopeptides / pharmacology
  • Oscillometry
  • Patch-Clamp Techniques
  • Peptides, Cyclic / pharmacology
  • Phorbol 12,13-Dibutyrate / pharmacology
  • Piperidines / pharmacology
  • Pulmonary Artery / cytology
  • Pulmonary Artery / drug effects
  • Pulmonary Artery / physiology*
  • Rats
  • Rats, Wistar
  • Ruthenium Red / pharmacology
  • Tetracaine / pharmacology
  • Thapsigargin / pharmacology

Substances

  • Endothelin Receptor Antagonists
  • Endothelin-1
  • Oligopeptides
  • Peptides, Cyclic
  • Piperidines
  • Tetracaine
  • Ruthenium Red
  • Phorbol 12,13-Dibutyrate
  • Caffeine
  • BQ 788
  • Niflumic Acid
  • Thapsigargin
  • Inositol 1,4,5-Trisphosphate
  • Neomycin
  • cyclo(Trp-Asp-Pro-Val-Leu)
  • Calcium